Lung Cancer

Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).

Lung Cancer

Lung cancer is a common and very serious form of cancer, with more than 40,000 people diagnosed with the condition each year in the UK. The symptoms of lung cancer do not present in the early stages, but when symptoms do eventually present, they usually include the following:

Palliative and End-of-Life Care in Lung Cancer

Exploring Diversity in Lung Cancer: Impact on Incidence, Prognosis, and Treatment Strategies

Lung Cancer Questions

Carcinogens in Cigarette Smoke

Pulmonary Transplant (Lung Transplant)

Lung Plethysmography Procedure

Lung Cancer Treatments

Lung Cancer Symptoms

Lung Cancer: Radiotherapy and Chemotherapy

Lung Cancer Risk Factors

Lung Cancer Research

See more featured articles »

Lung Cancer and Electrolyte Imbalances

Types of Lung Cancer Surgery

Pulmonary Resection in Lung Cancer

What Causes Lung Cancer in Non-Smokers?

Lymph Nodes in Lung Cancer

Secondary Lung Cancer

Everything You Need to Know About Giving Up Cigarettes

How to Prevent Lung Cancer

Epidemiology of Lung Cancer

Lung Cancer Pathogenesis

Lung Cancer in Women: Understanding the Increasing Risk

Lung Cancer Diagnosis

Lung Cancer Screening Procedure

Lung Cancer Causes

Immunotherapy: The Future of Lung Cancer Treatment?

Lung Cancer Genetics

What are the Survival Rates for Lung Cancer?

Latest Lung Cancer News and Research

Patients with a form of advanced lung cancer lived 56 percent longer without their disease progressing after receiving radiotherapy in addition to standard treatment

Patients with an advanced form of lung cancer lived 56 percent longer without their disease progressing when radiotherapy was added to the standard of care whole-body therapy, including chemotherapy and/or immunotherapy, according to initial results from a clinical trial presented at the 2026 European Society for Medical Oncology (ESMO) Congress.

27 Oct 2026

Immunotherapy combination sets a new standard of care for extensive-stage small cell lung cancer

In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab as first-line maintenance therapy extended median overall survival by more than eight months, more than tripled progression-free survival, and reduced the risk of death by 58% compared to durvalumab alone, according to results of the phase 3 open-label, multicenter, randomized DeLLphi-305 study, which was presented by Jacob Sands, MD, Associate Chief of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, during the Presidential Symposium at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain, on Oct. 24.

26 Oct 2026

Medical societies release landmark framework redefining women's heart health

Today, the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine released a landmark publication that redefines heart health in girls and women.

26 Oct 2026

New report urges unified lifecycle approach to women's heart health

A new approach to women's heart health may offer them a lifetime of opportunities. A trio of scientific papers, published today in the journal Circulation, spells out how fluctuating hormones, mental health and well-being, the heart and the brain are linked and how those connections need to be a routine part of care from a young age.

26 Oct 2026

Next generation KRAS inhibitor divarasib significantly extends lung cancer survival

Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and saw improved disease control when treated with the next-generation KRAS targeted therapy divarasib, according to researchers from The University of Texas MD Anderson Cancer Center.

26 Oct 2026

Study identifies potential new ways to treat the most common type of bowel cancer

Major new research published today identifies potential new ways to treat the most common type of bowel cancer in Ireland.

23 Oct 2026

Researchers harness cancer cells' carbon monoxide to produce anticancer drug

What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research Institute (PRI) in Japan.

23 Oct 2026

Dual-targeted therapy shows promise against metastatic triple-negative breast cancer

A new preclinical study suggests that attacking triple-negative breast cancer (TNBC) in two ways at once can kill cancer cells, slow tumor growth and limit the cancer's spread. Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) developed the approach.

23 Oct 2026

Study identifies potential treatment target for aggressive lung tumors

A UTHealth Houston-led team has identified a promising new avenue to curb the growth and spread of tumors associated with hard-to-treat lung and other cancers.

20 Oct 2026

Liquid biopsy reliably detects early-stage lung cancer recurrence risk

Despite advances in early-stage lung cancer treatment, a significant number of patients experience disease recurrence after surgery or initial therapy.

20 Oct 2026

Scientists discover immune pathway behind radiation-induced lung damage

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, have uncovered an immune pathway that may contribute to radiation-related lung damage and have identified a potential strategy to block it.

20 Oct 2026

MUSC study reveals gender shift in adolescent vaping trends

For decades, boys and men were more likely than their female peers to use nicotine. But a new study from MUSC shows that among U.S. adolescents, that pattern has reversed for vaping.

19 Oct 2026

Invisible no more: New treatment avenue unlocked for deadliest lung cancer

Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally.

16 Oct 2026

WEHI study reveals a new immune pathway for fighting small cell lung cancer

Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally.

14 Oct 2026

Scientists studied diet and lung cancer in 95,612 adults. One eating pattern stood out

A prospective study of 95,612 U.S. adults found that those with the highest sulfur microbial diet scores had a 23% higher adjusted lung cancer incidence hazard and a 19% higher lung cancer-related mortality hazard than those with the lowest scores. However, the associations weakened after accounting for overall dietary quality and competing causes of death, and the findings do not establish a causal relationship.

13 Oct 2026

A trial of 3,220 smokers puts cash rewards for quitting to the test

In a randomized trial of 3,220 medically underserved adults referred for lung cancer screening, adding financial incentives to usual care and free medication increased sustained smoking abstinence at six months. Offering free medication alone did not significantly increase quit rates, and adding a forward-looking mobile tool did not improve outcomes beyond the incentives.

11 Oct 2026

US counties with more medical debt see higher rates of several late-stage cancers

Higher medical debt is linked to more late-stage cancer diagnoses across U.S. counties.

9 Oct 2026

NCCN collaborates with global organizations to launch tailored cancer guidelines for Philippines

The National Comprehensive Cancer Network (NCCN)-an alliance of leading academic cancer centers in the United States-is collaborating with several global organizations to publish new International Adaptations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for the Philippines.

8 Oct 2026

Excess adiposity may alter the immune environment of airways to promote lung cancer

In a recent study of more than a thousand individuals, greater adiposity, or excessive body fat or fatty tissue, specifically in the abdomen, was associated with lung cancer.

8 Oct 2026